...
首页> 外文期刊>Cancer science. >P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer
【24h】

P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non-small-cell lung cancer

机译:P38通路是结缔组织生长因子调节非小细胞肺癌转移潜能的关键下游信号

获取原文
获取原文并翻译 | 示例
           

摘要

Although the secretory matricellular protein connective tissue growth factor (CTGF) has been reported to be related to lung cancer metastasis, the precise mechanism by which CTGF regulates lung cancer metastasis has not been elucidated. In the present study, we show the molecular link between CTGF secretion and the p38 pathway in the invasive and metastatic potential of non-small-cell lung cancer (NSCLC). Among three different human NSCLC cell lines (PC-14, A549, and PC-9), their in vitro invasiveness was inversely correlated with the level of CTGF secretion. By supplementing or reducing CTGF secretion in NSCLC culture, dysregulation of the invasive and metastatic potential of NSCLC cell lines was largely compensated. By focusing on the protein kinases that are known to be regulated by CTGF, we found that the p38 pathway is a key downstream signal of CTGF to regulate the metastatic potential of NSCLC. Importantly, a negative correlation between CTGF and phosphorylation status of p38 was identified in The Cancer Genome Atlas lung adenocarcinoma dataset. In the context of the clinical importance of our findings, we showed that p38 inhibitor, SB203580, reduced the metastatic potential of NSCLC secreting low levels of CTGF. Collectively, our present findings indicate that the CTGF/p38 axis is a novel therapeutic target of NSCLC metastasis, particularly NSCLC secreting low levels of CTGF.
机译:尽管据报道分泌性基质细胞蛋白结缔组织生长因子(CTGF)与肺癌转移有关,但尚未阐明CTGF调节肺癌转移的确切机制。在本研究中,我们显示了非小细胞肺癌(NSCLC)侵袭和转移潜力中CTGF分泌与p38途径之间的分子联系。在三种不同的人类NSCLC细胞系(PC-14,A549和PC-9)中,它们的体外侵袭性与CTGF分泌水平成反比。通过补充或减少NSCLC培养物中CTGF的分泌,NSCLC细胞系的侵袭和转移潜能失调得到了很大的补偿。通过关注已知受CTGF调节的蛋白激酶,我们发现p38途径是CTGF调节NSCLC转移潜能的关键下游信号。重要的是,在《癌症基因组图集》肺腺癌数据集中确定了CTGF与p38磷酸化状态之间的负相关性。在我们发现的临床重要性的背景下,我们显示p38抑制剂SB203580降低了分泌低水平CTGF的NSCLC的转移潜力。总的来说,我们目前的发现表明CTGF / p38轴是NSCLC转移的新治疗靶标,尤其是分泌低水平CTGF的NSCLC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号